These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 10470201)

  • 21. [Immunohistochemical demonstration of L- and M2-pyruvate kinase in primary renal cell carcinomas and their metastases].
    Fischer G; Holzrichter S; Reinacher M; Heinrichs M; Dembowski J; Eigenbrodt E
    Verh Dtsch Ges Pathol; 1989; 73():422-7. PubMed ID: 2482632
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor M2-pyruvate kinase: a promising tumor marker in the diagnosis of gastro-intestinal cancer.
    Hardt PD; Ngoumou BK; Rupp J; Schnell-Kretschmer H; Kloer HU
    Anticancer Res; 2000; 20(6D):4965-8. PubMed ID: 11326648
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the tumor markers tumor M2-PK, CEA, CYFRA 21-1, NSE and SCC in the diagnosis of lung cancer.
    Schneider J; Velcovsky HG; Morr H; Katz N; Neu K; Eigenbrodt E
    Anticancer Res; 2000; 20(6D):5053-8. PubMed ID: 11326667
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantification of tumor type M2 pyruvate kinase (Tu M2-PK) in human carcinomas.
    Eigenbrodt E; Basenau D; Holthusen S; Mazurek S; Fischer G
    Anticancer Res; 1997; 17(4B):3153-6. PubMed ID: 9329624
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor M2 pyruvate kinase: a tumor marker and its clinical application in gastrointestinal malignancy.
    Hardt PD; Ewald N
    Expert Rev Mol Diagn; 2008 Sep; 8(5):579-85. PubMed ID: 18785806
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma levels of HER-2/neu, tumor type M2 pyruvate kinase and its tyrosine-phosphorylated metabolite in advanced breast cancer.
    Lüftner D; Mazurek S; Henschke P; Mesterharm J; Schildhauer S; Geppert R; Wernecke KD; Possinger K
    Anticancer Res; 2003; 23(2A):991-7. PubMed ID: 12820337
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pyruvate kinase type tumor M2 plasma levels in patients afflicted with rheumatic diseases.
    Oremek GM; Müller R; Sapoutzis N; Wigand R
    Anticancer Res; 2003; 23(2A):1131-4. PubMed ID: 12820360
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma concentrations of tumour dimeric pyruvate kinase are increased in patients with chronic cardiac failure.
    McDowell G; Gupta S; Dellerba M; Coppinger T; Levy RD; Keevil BG
    Ann Clin Biochem; 2004 Nov; 41(Pt 6):491-3. PubMed ID: 15588442
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor M2-pyruvate kinase in lung cancer patients: immunohistochemical detection and disease monitoring.
    Schneider J; Neu K; Grimm H; Velcovsky HG; Weisse G; Eigenbrodt E
    Anticancer Res; 2002; 22(1A):311-8. PubMed ID: 12017309
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparison of tumour M2-PK with carcinoembryonic antigen and CA19-9 in patients undergoing liver resection for colorectal metastases.
    Kumar Y; Pinedo IR; Tapuria N; Zabron A; Davidson BR
    Eur J Gastroenterol Hepatol; 2008 Oct; 20(10):1006-11. PubMed ID: 18787469
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor marker M2-pyruvate-kinase in differential diagnosis of chronic pancreatitis and pancreatic cancer.
    Novotný I; Dítĕ P; Dastych M; Záková A; Trna J; Novotná H; Nechutová H
    Hepatogastroenterology; 2008; 55(85):1475-7. PubMed ID: 18795715
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pyruvate kinase type tumor M2 in urological malignancies.
    Hegele A; Varga Z; Kosche B; Stief T; Heidenreich A; Hofmann R
    Urol Int; 2003; 70(1):55-8. PubMed ID: 12566817
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tu-M2-PK in the blood of testicular and cubital veins in men with testicular cancer.
    Pottek T; Müller M; Blum T; Hartmann M
    Anticancer Res; 2000; 20(6D):5029-33. PubMed ID: 11326662
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improved sensitivity in the diagnosis of gastro-intestinal tumors by fuzzy logic-based tumor marker profiles including the tumor M2-PK.
    Schneider J; Bitterlich N; Schulze G
    Anticancer Res; 2005; 25(3A):1507-15. PubMed ID: 16033052
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The tumor marker tumor M2-PK: an application in the diagnosis of gastrointestinal cancer.
    Schulze G
    Anticancer Res; 2000; 20(6D):4961-4. PubMed ID: 11326647
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma levels of tumor M2-pyruvate kinase should not be used as a tumor marker for hematological malignancies and solid tumors.
    Staib P; Hoffmann M; Schinköthe T
    Clin Chem Lab Med; 2006; 44(1):28-31. PubMed ID: 16375581
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [M2-type pyruvate kinase in the diagnosis of hepatocarcinoma--a pilot study].
    Liu JB
    Zhonghua Zhong Liu Za Zhi; 1990 May; 12(3):166-9. PubMed ID: 2174328
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Value of the serum levels of the tumor marker TUM2-PK in pancreatic cancer.
    Oremek GM; Eigenbrodt E; Rädle J; Zeuzem S; Seiffert UB
    Anticancer Res; 1997; 17(4B):3031-3. PubMed ID: 9329593
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determination of pyruvate kinase type tumor M2 in human renal cell carcinoma: a suitable tumor marker?
    Varga Z; Hegele A; Stief T; Heidenreich A; Hofmann R
    Urol Res; 2002 May; 30(2):122-5. PubMed ID: 12086017
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumour M2-pyruvate kinase: a gastrointestinal cancer marker.
    Kumar Y; Tapuria N; Kirmani N; Davidson BR
    Eur J Gastroenterol Hepatol; 2007 Mar; 19(3):265-76. PubMed ID: 17301655
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.